Literature DB >> 17997774

Tomographic assessment of therapeutic response to uveitic macular oedema.

Sobha Sivaprasad1, Felicia Ikeji, Wen Xing, Sue Lightman.   

Abstract

PURPOSE: To evaluate the therapeutic effects on the different morphological patterns of uveitic macular oedema and central macular thickness using optical coherence tomography (OCT).
METHODS: Retrospective observational case series. Fifty consecutive patients with a clinical diagnosis of new or recurrent macular oedema due to uveitis were examined with serial OCTs for 1 year. The correlation between different patterns of macular oedema (diffuse macular oedema, inner cystoid oedema, outer cystoid oedema, oedema involving both inner and outer layers of retina and serous retinal detachment) and change in logMAR visual acuity and the recorded variables including age, gender, systemic disease associated with uveitis, location and duration of uveitis, and duration of macular oedema were examined. Response to treatment was measured as change in logMAR visual acuity and evolution of patterns of macular oedema.
RESULTS: Diffuse macular oedema, external cystoid and serous retinal detachment responded well to treatment. Cysts in the inner retinal layers were more resistant to treatment. The cysts in the outer layers disappeared faster than cysts in the inner layers in patients with cysts in both layers at baseline. Multivariate analysis showed that cystoid macular oedema (all types) (P = 0.03) and inner cystoid oedema (P = 0.031) were the variables significantly associated with final visual acuity.
CONCLUSION: Assessment of patterns of uveitic macular oedema by OCT gives useful information on the prognosis. Inner retinal cystoid oedema is more resistant to treatment than any other patterns of oedema.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997774     DOI: 10.1111/j.1442-9071.2007.01577.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  8 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

Review 2.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

3.  Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.

Authors:  Oren Tomkins-Netzer; Susan Lightman; Lea Drye; John Kempen; Gary N Holland; Narsing A Rao; Richard J Stawell; Albert Vitale; Douglas A Jabs
Journal:  Ophthalmology       Date:  2015-09-07       Impact factor: 12.079

4.  Fundus autofluorescence and spectral domain optical coherence tomography in uveitic macular edema.

Authors:  Martin Roesel; Andreas Henschel; Carsten Heinz; Martha Dietzel; Georg Spital; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

5.  The impact of macular edema on visual function in intermediate, posterior, and panuveitis.

Authors:  Simon R J Taylor; Susan L Lightman; Elizabeth A Sugar; Glen J Jaffe; William R Freeman; Michael M Altaweel; Igor Kozak; Janet T Holbrook; Douglas A Jabs; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2012-04-24       Impact factor: 3.070

6.  Characterization of serous retinal detachments in uveitis patients with optical coherence tomography.

Authors:  Annamieka Simmons-Rear; Steven Yeh; Brian T Chan-Kai; Andreas K Lauer; Christina J Flaxel; Justine R Smith; James T Rosenbaum; Eric B Suhler
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-06-02

7.  Quantitative effect of subretinal fluid and intraretinal edema on visual acuity in uveitic cystoid macular edema.

Authors:  Eric W Weldy; Jennifer L Patnaik; Paula E Pecen; Alan G Palestine
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-10-11

8.  A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.

Authors:  Bruno Simonazzi; Konstantinos Balaskas; Yan Guex-Crosier
Journal:  BMC Ophthalmol       Date:  2016-05-18       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.